Publisher
Norwegian Medical Association
Reference14 articles.
1. Karlsen TH, Folseraas T, Thorburn D et al. Primary sclerosing cholangitis - a comprehensive review. J Hepatol 2017; 67: 1298–323. [PubMed][CrossRef]
2. Boonstra K, Weersma RK, van Erpecum KJ et al. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatology 2013; 58: 2045–55. [PubMed][CrossRef]
3. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on sclerosing cholangitis. J Hepatol 2022; 77: 761–806. [CrossRef]
4. Weismüller TJ, Trivedi PJ, Bergquist A et al. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis. Gastroenterology 2017; 152: 1975–1984.e8. [PubMed][CrossRef]
5. Bowlus CL, Arrivé L, Bergquist A et al. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology 2023; 77: 659–702. [PubMed][CrossRef]